Intermolecular

Intermolecular develops advanced materials for semiconductor, consumer electronics, automotive and aerospace industries. Read more

Chris Kramer's photo - President & CEO of Intermolecular

President & CEO

Chris Kramer

CEO Approval Rating

61/100

Founded:

2004

Status:

PrivateSubsidiary of Merck KGaA

INTERMOLECULAR TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Zyvex Labs is one of Intermolecular's top rivals. Zyvex Labs was founded in Richardson, Texas} in 1997. Like Intermolecular, Zyvex Labs also competes in the Semiconductors & Semiconductor Equipment space. Compared to Intermolecular, Zyvex Labs generates $15.9M less revenue.

PVD Products is Intermolecular's #2 competitor. PVD Products was founded in 1995, and is headquartered in Wilmington, Massachusetts. Like Intermolecular, PVD Products also operates in the Semiconductors & Semiconductor Equipment space. PVD Products generates $12M less revenue vs. Intermolecular.

Nanosys is a top competitor of Intermolecular. Nanosys's headquarters is in Milpitas, California, and was founded in 2001. Like Intermolecular, Nanosys also works within the Semiconductors & Semiconductor Equipment sector. Nanosys generates 193% of Intermolecular's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 88 a good estimate for Intermolecular's Employee count?

Intermolecular Acquisitions

No recent acquisitions found related to Intermolecular

Intermolecular Funding History

Since Intermolecular was founded in 2004, it has participated in 1 round of funding. In total Intermolecular has raised $96.5M. Intermolecular's funding round was on Nov 2011 for a total of $96.5M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Nov 2011
$96.5M
-

Since Intermolecular was founded in 2004, it has participated in 1 round of funding. In total Intermolecular has raised $96.5M. Intermolecular's funding round was on Nov 2011 for a total of $96.5M

Intermolecular Investments

No recent investments found related to Intermolecular

Intermolecular News

July 2, 2019BioPortfolio

INTERMOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick & Foti LLC Investigates Adequacy of Price and Process in Proposed Sale of Intermolecular Inc. IMI

Former Attorney General of Louisiana Charles C. Foti Jr. Esq. and the law firm of Kahn Swick & Foti L... See more »
June 25, 2019Benzinga

Rigrodsky & Long, P.A. Files Class Action Suit Against Intermolecular, Inc.

WILMINGTON, Del., June 25, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.:Rigrodsky & Long, P.A. ann... See more »
May 14, 20194-traders

Reports First Quarter 2019 Financial Results

(marketscreener.com) SAN JOSE, Calif., May 14, 2019 /PRNewswire/ -- Intermolecular, Inc. (Nasdaq: IMI... See more »
May 7, 2019Evertiq

Intermolecular to be acquired by Merck KGaA

Intermolecular has signed a definitive agreement under which a wholly owned subsidiary of Merck KGaA,... See more »
May 6, 20194-traders

INTERMOLECULAR, INC. Rigrodsky & Long, P.A. Announces Investigation Of Buyout

(marketscreener.com) WILMINGTON, Del., May 06, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do yo... See more »
August 23, 2018Benzinga

Intermolecular to Present at the 7th Annual Liolios Gateway Conference on September 5, 2018

SAN JOSE, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Intermolecular, Inc. (NASDAQ:IMI), the trusted pa... See more »

Intermolecular Blogs

July 7, 2016Intermolecular Blog

Intermolecular Announces First Quarter 2016 Financial Results

May 5, 2016 SAN JOSE, Calif., May 5, 2016 /PRNewswire/ - Intermolecular, Inc. (NASDAQ: IMI) today rep... See more »
July 7, 2016Intermolecular Blog

Lore ipsum post 1

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the i... See more »
July 7, 2016Intermolecular Blog

Lore ipsum post 2

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the i... See more »
July 7, 2016Intermolecular Blog

Lore ipsum post 4

Lorem Ipsum is simply dummy text of ...The post Lore ipsum post 4 appeared first on IMI | Intermolecu... See more »

Intermolecular Press Releases

April 24, 2019PR Newswire

Intermolecular Sets Fiscal First Quarter 2019 Earnings Call for Tuesday, May 14, 2019 at 5 p.m. ET

SAN JOSE, Calif., April 24, 2019 /PRNewswire/ -- Intermolecular, Inc. (NASDAQ: IMI), the trusted part... See more »
February 13, 2019CENTRALCHARTS

Intermolecular Reports Fourth Quarter and Full Year 2018 Financial Results

Intermolecular, Inc. (Nasdaq: IMI), the trusted partner for advanced materials innovation, today repo... See more »
January 24, 2019PR NewsWire Sys-Con Media

Intermolecular Sets Fiscal Fourth Quarter and Full Year 2018 Earnings Call for Tuesday, February 12, 2019 at 5 p.m. ET

SAN JOSE, Calif., Jan. 24, 2019 /PRNewswire/ -- Intermolecular, Inc. (NASDAQ: IMI), the trusted partn... See more »
November 27, 2018centralcharts

Intermolecular Sets December 2018 Financial Conference Schedule

Intermolecular, Inc. (NASDAQ: IMI), the trusted partner for advanced materials innovation, has been i... See more »
November 6, 2018PR Newswire

Intermolecular Board of Directors Authorizes $10 Million Share Repurchase Program

SAN JOSE, Calif., Nov. 6, 2018 /PRNewswire/ -- The board of directors of Intermolecular, Inc. (Nasdaq... See more »
November 6, 2018PR Newswire

Intermolecular Reports Third Quarter and Nine Month 2018 Financial Results

SAN JOSE, Calif., Nov. 6, 2018 /PRNewswire/ -- Intermolecular, Inc. (Nasdaq: IMI), the trusted partne... See more »
October 16, 2018centralcharts

Intermolecular Sets Fiscal Third Quarter 2018 Earnings Call for Tuesday, November 6, 2018 at 5 p.m. ET

SAN JOSE, Calif., Oct. 16, 2018 /PRNewswire/ -- Intermolecular, Inc. (NASDAQ: IMI), the trusted partn... See more »

Social Media

Intermolecular Headquarters

3011 N 1st Street

San Jose, California95134

408-582-5700

Driving Directions »

Trending Companies

Intermolecular Summary

ABOUT

Overview

Intermolecular develops advanced materials for semiconductor, consumer electronics, automotive and aerospace industries. Intermolecular was founded in 2004. Intermolecular's headquarters is located in San Jose, California, USA 95134. It has raised 96....

CEO

Intermolecular's President & CEO, Chris Kramer, currently has an approval rating of 61%. Intermolecular's primary competitors are Zyvex Labs, PVD Products & Nanosys.

Frequently Asked Questions about Intermolecular

  1. When was Intermolecular founded?

    Intermolecular was founded in 2004
  2. Who is Intermolecular's CEO?

    Intermolecular's CEO is Chris Kramer
  3. How much revenue does Intermolecular generate?

    Intermolecular generates $25.9M in revenue
  4. How much funding does Intermolecular have?

    Intermolecular has historically raised $96.5M in funding
  1. Where is Intermolecular's headquarters?

    Intermolecular's headquarters is in San Jose California, USA
  2. How many employees does Intermolecular have?

    Intermolecular has 88 employees
  3. What sector does Intermolecular operate in?

    Intermolecular is in Semiconductors & Semiconductor Equipment, Electronic Equipment
  4. Who are Intermolecular's competitors?

    Intermolecular's top competitors are Zyvex Labs, PVD Products, Nanosys